USA: Pearl River, NY, Pfizer Vaccine Research and Development
Pearl River, NY is the headquarters of Pfizer's Vaccine R&D organization, where Pfizer scientists are currently working to develop vaccines against major infectious diseases. Located less than 30 miles from midtown Manhattan and accessible via shuttle bus including pickup/drop off stops close to Columbia University, the Pearl River site is well into its second century as a New York-area center for vaccine innovation that impacts healthcare around the world. Today it is focusing its efforts to apply leading-edge science towards helping fight COVID-19 and bring the next generation of prophylactic and viral vaccines to vulnerable people of all ages.
The Programs in Global Health at VP&S and Pfizer's Vaccine R&D organization partnered up since early 2020 to offer a number of sponsored and exciting opportunities at Pfizer's Vaccine R&D organization. Interested students may submit their application through the Program for Education in Global and Population Health.
Columbia University Faculty Liaison: Lawrence Stanberry, MD, PhD
Program Manager: Molly Borst (Molly.Borst@pfizer.com)
Research opportunities available at this site:
Summer Research Projects, Scholarly Projects
Thematic Research Areas at this site:
Infectious Diseases
Global Pop funds students from the following CUIMC Schools at this site:
VP&S, MSPH
Language requirement:
No
Potential activities that could be carried out by students at this site:
Literature Review, Attend regular Team/Site meetings, Data collection, Data monitoring, Data analysis, Program monitoring and evaluation, Manuscript writing, Summarizing/Disseminating results, Shadowing, Attending and presenting lectures, Lab work
Other requirements or information:
This site offers on-site orientation.
About Projects with Pfizer in 2023
Student Participation: In-person
Number of Students: 1
Projects with Pfizer in 2022
Mentored Research Projects - 2021
Antibiotic resistance-associated gene identification among invasive Group B Streptococcus samples and analysis of potential vaccine targets
Pfizer Mentors: Hal Jones, PhD, Li Hao, PhD
Student: Emma Senner (MSPH)
Development of Vaccine Against Group B Streptococcus: Current Status and Future Perspectives
Pfizer Mentors: Yekaterina Timofeyeva, MS, Isis Kanevsky, PhD
Student: Sneha Kunwar (MSPH)
Intrapartum antibiotic prophylaxis for prevention of neonatal group B streptococcal disease: a review of key limitations and their implications for vaccine development
Pfizer Mentor: Raphael Simon, PhD
Student: Peter Suwondo (VP&S)